tazarotene has been researched along with Itching in 9 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Safety and treatment emergent adverse events (TEAEs) were evaluated throughout." | 6.90 | Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials ( Israel, R; Lebwohl, MG; Lin, T; Stein Gold, L; Sugarman, JL, 2019) |
| " Treatment-related adverse effects were generally limited to mild or moderate local irritation and were less frequent with the treatment regimen administered once daily." | 6.69 | The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. ( Chandraratna, RA; Drake, LA; Elias, PM; Guzzo, C; Krueger, GG; Lew-Kaya, DA; Lowe, NJ; Lue, JC; Sefton, J; Weinstein, GD, 1998) |
| " Safety and treatment emergent adverse events (TEAEs) were evaluated throughout." | 2.90 | Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials ( Israel, R; Lebwohl, MG; Lin, T; Stein Gold, L; Sugarman, JL, 2019) |
| " Treatment-related adverse effects were generally limited to mild or moderate local irritation and were less frequent with the treatment regimen administered once daily." | 2.69 | The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. ( Chandraratna, RA; Drake, LA; Elias, PM; Guzzo, C; Krueger, GG; Lew-Kaya, DA; Lowe, NJ; Lue, JC; Sefton, J; Weinstein, GD, 1998) |
| " Our purpose is to compare the rates of adverse events associated with different topical psoriasis treatments." | 2.42 | A systematic review of adverse effects associated with topical treatments for psoriasis. ( Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Lebwohl, MG | 1 |
| Sugarman, JL | 1 |
| Stein Gold, L | 2 |
| Lin, T | 2 |
| Israel, R | 1 |
| Elewski, B | 1 |
| Draelos, Z | 1 |
| Jacobson, A | 1 |
| He, C | 1 |
| Jin, H | 1 |
| Liu, X | 1 |
| Hu, F | 1 |
| Zhang, L | 2 |
| Zhang, S | 1 |
| He, Y | 1 |
| Yang, X | 1 |
| Chen, H | 1 |
| Wang, X | 1 |
| Ji, C | 1 |
| Lv, C | 1 |
| Miao, G | 1 |
| Li, X | 2 |
| Diao, Q | 1 |
| Li, L | 1 |
| Li, Y | 1 |
| Wang, R | 1 |
| Zhou, X | 1 |
| Xia, X | 1 |
| Yan, M | 1 |
| Song, J | 1 |
| Zhang, R | 1 |
| Geng, L | 1 |
| Zheng, M | 1 |
| Lu, Q | 1 |
| Lu, T | 1 |
| Shi, Y | 1 |
| Jing, H | 1 |
| Zhang, X | 1 |
| Shi, J | 1 |
| Xia, J | 1 |
| Gao, Y | 1 |
| Wang, Y | 1 |
| Puente, N | 1 |
| Nieto, O | 1 |
| Tardío, JC | 1 |
| Borbujo, J | 1 |
| Youssef, SM | 1 |
| Teng, JM | 1 |
| Bruner, CR | 1 |
| Feldman, SR | 1 |
| Ventrapragada, M | 1 |
| Fleischer, AB | 1 |
| Dosik, JS | 1 |
| Arsonnaud, S | 1 |
| Krueger, GG | 1 |
| Drake, LA | 1 |
| Elias, PM | 1 |
| Lowe, NJ | 1 |
| Guzzo, C | 1 |
| Weinstein, GD | 1 |
| Lew-Kaya, DA | 1 |
| Lue, JC | 1 |
| Sefton, J | 1 |
| Chandraratna, RA | 1 |
| Koo, JY | 1 |
| Martin, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Excimer Laser Combined With Either Topical Tazarotene or Topical Betamethasone Valerate Versus Excimer Laser Alone in Treatment of Localized Chronic Plaque Psoriasis; Clinical and Dermoscopic Study[NCT05555797] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-10-30 | Not yet recruiting | ||
| Spray® and Vectical Ointment® in the Treatment of Plaque Psoriasis[NCT01205880] | Phase 4 | 12 participants (Actual) | Interventional | 2009-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for tazarotene and Itching
| Article | Year |
|---|---|
Effective topical combination therapy for treatment of lichen striatus in children: a case series and review.
Topics: Administration, Cutaneous; Child; Child, Preschool; Dermatologic Agents; Drug Therapy, Combination; | 2012 |
A systematic review of adverse effects associated with topical treatments for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agen | 2003 |
5 trials available for tazarotene and Itching
| Article | Year |
|---|---|
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials
Topics: Adult; Clobetasol; Dermatitis, Contact; Dermatologic Agents; Double-Blind Method; Drug Combinations; | 2019 |
Halobetasol 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Males and Females.
Topics: Adult; Aged; Clobetasol; Dermatitis, Contact; Double-Blind Method; Drug Combinations; Female; Humans | 2020 |
Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.
Topics: Adapalene; Administration, Cutaneous; Adult; Aged; Dermatitis, Irritant; Dermatologic Agents; Female | 2007 |
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Double-Blind Method; Drug Administration Sche | 1998 |
Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dermatologic Agents; Drug Eruptions; Drug Therapy, Combinatio | 2001 |
2 other studies available for tazarotene and Itching
| Article | Year |
|---|---|
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatologic Agents; Drug | 2021 |
Unilateral and pruritic papules: segmental Darier-White disease.
Topics: Abdominal Wall; Adult; Anti-Inflammatory Agents; Darier Disease; Drug Therapy, Combination; Female; | 2014 |